Danhauer Suzanne C, Tooze Janet A, Holder Paige, Miller Christina, Jesse Michelle T
Department of Internal Medicine, Section of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1082, USA.
J Soc Integr Oncol. 2008 Summer;6(3):89-97.
Goals were to determine the feasibility of conducting a study of Healing Touch (HT) for acute leukemia patients and to obtain preliminary data on its effectiveness.
Forty hospitalized leukemia patients completed a brief survey of HT knowledge/experience. A prospective cohort (N = 12) was invited to participate in an HT intervention (9 30-minute sessions over 3 weeks); they completed measures of distress, symptoms, and sleep (at weeks 1 and 5), and completed single item ratings of fatigue, nausea, distress, and pain immediately pre-post selected HT sessions. The Wilcoxon signed rank test was used to analyze change in pre-post session ratings and distress, symptom, and sleep measures.
Among survey respondents, 8% had used HT in the past, and 71% were interested in using HT. In the prospective cohort, there were significant pre-post session improvements in fatigue and nausea (but not in distress and pain). There were no significant changes between weeks 1 and 5 in distress, symptoms, or sleep. Ratings and qualitative feedback on HT were positive, focused mainly on feeling relaxed following HT sessions.
It is feasible to recruit patients hospitalized for acute leukemia to a study of HT. Preliminary data on short-term improvements in symptoms indicate these are promising outcomes for future study.
目标是确定对急性白血病患者开展一项治疗性触摸(HT)研究的可行性,并获取其有效性的初步数据。
40名住院白血病患者完成了一项关于HT知识/经验的简短调查。邀请了一个前瞻性队列(N = 12)参与HT干预(在3周内进行9次30分钟的疗程);他们完成了痛苦、症状和睡眠的测量(在第1周和第5周),并在选定的HT疗程前后立即完成了疲劳、恶心、痛苦和疼痛的单项评分。采用Wilcoxon符号秩检验分析疗程前后评分以及痛苦、症状和睡眠测量的变化。
在调查受访者中,8%的人过去使用过HT,71%的人有兴趣使用HT。在前瞻性队列中,疗程前后疲劳和恶心有显著改善(但痛苦和疼痛没有)。在第1周和第5周之间,痛苦、症状或睡眠没有显著变化。对HT的评分和定性反馈是积极的,主要集中在HT疗程后感觉放松。
招募住院的急性白血病患者参与HT研究是可行的。关于症状短期改善的初步数据表明这些是未来研究的有希望的结果。